HRP20211303T1 - Pripravci koji sadrže silimarin i sulfoalkil eter ciklodekstrin i postupci korištenja istih - Google Patents

Pripravci koji sadrže silimarin i sulfoalkil eter ciklodekstrin i postupci korištenja istih Download PDF

Info

Publication number
HRP20211303T1
HRP20211303T1 HRP20211303TT HRP20211303T HRP20211303T1 HR P20211303 T1 HRP20211303 T1 HR P20211303T1 HR P20211303T T HRP20211303T T HR P20211303TT HR P20211303 T HRP20211303 T HR P20211303T HR P20211303 T1 HRP20211303 T1 HR P20211303T1
Authority
HR
Croatia
Prior art keywords
isosilybin
silybin
preparation
sulfoalkyl ether
amount
Prior art date
Application number
HRP20211303TT
Other languages
English (en)
Croatian (hr)
Inventor
James D. Pipkin
Roger Rajewski
Beau MAINOUS
Original Assignee
Cydex Pharmaceuticals, Inc.
University Of Kansas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cydex Pharmaceuticals, Inc., University Of Kansas filed Critical Cydex Pharmaceuticals, Inc.
Publication of HRP20211303T1 publication Critical patent/HRP20211303T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/738—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Inorganic Chemistry (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
HRP20211303TT 2015-03-19 2016-03-18 Pripravci koji sadrže silimarin i sulfoalkil eter ciklodekstrin i postupci korištenja istih HRP20211303T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562135625P 2015-03-19 2015-03-19
PCT/US2016/023309 WO2016149685A1 (en) 2015-03-19 2016-03-18 Compositions containing silymarin and sulfoalkyl ether cyclodextrin and methods of using the same
EP16765878.0A EP3270941B1 (en) 2015-03-19 2016-03-18 Compositions containing silymarin and sulfoalkyl ether cyclodextrin and methods of using the same

Publications (1)

Publication Number Publication Date
HRP20211303T1 true HRP20211303T1 (hr) 2021-11-12

Family

ID=56919564

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20211303TT HRP20211303T1 (hr) 2015-03-19 2016-03-18 Pripravci koji sadrže silimarin i sulfoalkil eter ciklodekstrin i postupci korištenja istih

Country Status (9)

Country Link
US (4) US10702568B2 (https=)
EP (3) EP3939582B1 (https=)
JP (2) JP6971963B2 (https=)
CN (1) CN108348560A (https=)
CA (1) CA2980170A1 (https=)
ES (1) ES3029362T3 (https=)
HR (1) HRP20211303T1 (https=)
MX (2) MX384365B (https=)
WO (1) WO2016149685A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108348560A (zh) 2015-03-19 2018-07-31 锡德克斯药物公司 包含水飞蓟素和磺烃基醚环糊精的组合物及其使用方法
US20190060212A1 (en) * 2017-08-23 2019-02-28 Roman Aleksandrovich Cosmetic Cream with Anti-Oxidant Activity
RU2645092C1 (ru) * 2017-10-05 2018-02-15 Сергей Александрович Староверов Гепатопротекторная инъекционная фармацевтическая композиция на основе силимарина и наночастиц селена
KR102050286B1 (ko) * 2018-02-08 2019-12-02 전북대학교산학협력단 건강기능식품 및 이의 제조방법
US12150949B2 (en) 2018-07-30 2024-11-26 Curology, Inc. Compositions and methods of treating acne and photoaging
KR102143405B1 (ko) * 2018-11-16 2020-08-11 한국화학연구원 리그난 포접물 및 이의 제조 방법
CN115701985A (zh) * 2020-04-16 2023-02-14 伊万涅姆医疗保健股份有限公司 具有硫胺素的二氢槲皮素制剂
CN113197877B (zh) * 2021-04-02 2022-11-11 海南普利制药股份有限公司 包含水飞蓟素的药物组合物
CN117915910A (zh) * 2021-09-21 2024-04-19 株式会社漫丹 免疫相关细胞的初级纤毛的抑制剂及其应用
KR102582322B1 (ko) * 2023-03-27 2023-09-26 (주)이너네이쳐 밀크씨슬 추출물이 포함되는 간 보호용 건강기능식품 조성물 및 이의 제조방법
CN117547515B (zh) * 2023-11-20 2024-04-16 黑龙江中医药大学 一种含有平贝母的口腔片剂及其制备方法
CN118178391B (zh) * 2024-05-14 2024-07-16 深圳北京大学香港科技大学医学中心 异水飞蓟宾a在缓解玫瑰痤疮中的应用

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3426011A (en) 1967-02-13 1969-02-04 Corn Products Co Cyclodextrins with anionic properties
US4783443A (en) 1986-03-03 1988-11-08 The University Of Chicago Amino acyl cephalosporin derivatives
US4847071A (en) 1987-10-22 1989-07-11 The Procter & Gamble Company Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent
GB8909095D0 (en) 1989-04-21 1989-06-07 Allied Colloids Ltd Thickened aqueous compositions
US5087445A (en) 1989-09-08 1992-02-11 Richardson-Vicks, Inc. Photoprotection compositions having reduced dermal irritation
IT1241673B (it) 1989-10-09 1994-01-27 Istituto Biochimico Italiano Complessi di inclusione di silibinina con ciclodestrina, loro preparazione e composizioni farmaceutiche che li contengono.
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
DE69127256T2 (de) 1990-05-21 1998-02-12 Toppan Printing Co Ltd Cyclodextrinderivat
DE4101122A1 (de) 1991-01-16 1992-07-23 Betrix Cosmetic Gmbh & Co Kosmetisches oder pharmazeutisches mittel
IT1253431B (it) * 1991-12-02 1995-08-08 Valetudo S R L Preparati farmaceutici per uso topico destinati al trattamento della psoriasi e della dermatite atopica
DE4401902C2 (de) 1994-01-24 2000-02-03 Madaus Ag Verwendung von Flavolignanen als Adjuvans in der Tumortherapie
US5874418A (en) 1997-05-05 1999-02-23 Cydex, Inc. Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use
ES2257795T3 (es) 1997-07-01 2006-08-01 Pfizer Products Inc. Procedimiento para producir una ciclodextrina.
US5997887A (en) 1997-11-10 1999-12-07 The Procter & Gamble Company Skin care compositions and method of improving skin appearance
US5972993A (en) 1998-03-20 1999-10-26 Avon Products, Inc. Composition and method for treating rosacea and sensitive skin with free radical scavengers
US6187822B1 (en) 1999-06-11 2001-02-13 University Of Medicine & Dentistry Of Nj Wound treatment through inhibition of adenosine diphosphate ribosyl transferase
TWI242015B (en) 1999-11-29 2005-10-21 Akzo Nobel Nv 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
KR20030041577A (ko) 2001-11-20 2003-05-27 디디에스텍주식회사 난용성 약물과 치환된 시클로덱스트린을 함유하는고체분산체 및 이를 함유하는 약제학적 조성물
CN1164269C (zh) 2002-08-16 2004-09-01 广州瑞济生物技术有限公司 含环糊精或其衍生物的水飞蓟素注射液
CN1424112A (zh) * 2002-12-17 2003-06-18 上海医药工业研究院 难溶性药物的水溶性包合物及其制备方法
JP4689468B2 (ja) 2003-07-10 2011-05-25 協和発酵バイオ株式会社 錠剤およびその製造方法
WO2005042584A2 (en) 2003-10-31 2005-05-12 The University Of Kansas Sulfoalkyl ether-alkyl ether cyclodextrin derivatives
CN1679542A (zh) 2004-04-06 2005-10-12 山东绿叶天然药物研究开发有限公司 水飞蓟宾盐冻干粉针及其制备方法
MXPA06012777A (es) * 2004-05-06 2007-02-14 Cydex Inc Formulaciones de sabor enmascarado que contienen sertralina y eter sulfoalquilico-ciclodextrina.
CN1593591A (zh) * 2004-07-13 2005-03-16 邢为藩 一种水飞蓟提取物环糊精包合物的制备方法及其药物制剂
FR2881953A1 (fr) * 2005-02-11 2006-08-18 Greenpharma Sa Sa Utilisation de derives de la taxifoline comme agents pigmentants et protecteurs de la peau ou des cheveux
JP4033877B2 (ja) 2005-09-29 2008-01-16 株式会社ファンケル Ｉ型コラーゲン産生促進用組成物
DK1945228T4 (da) 2005-10-26 2015-01-12 Cydex Pharmaceuticals Inc Sulfoalkyl-ether-cyclodextrin-sammensætninger og fremgangsmåder til fremstilling deraf
JP5351414B2 (ja) 2006-12-25 2013-11-27 株式会社ファンケル シリビン含有化粧料組成物
US7993630B2 (en) * 2007-02-17 2011-08-09 Bioderm Research Protection of skin from UV and peroxide
WO2009018326A2 (en) * 2007-07-31 2009-02-05 Limerick Biopharma, Inc. Soluble pyrone analogs methods and compositions
CZ300846B6 (cs) 2008-06-26 2009-08-26 Agra Group, A. S. Vodorozpustný prípravek na bázi flavanonol lignanu a zpusob jeho prípravy
KR20100052262A (ko) 2008-11-10 2010-05-19 (주)아모레퍼시픽 난용성 약물의 나노입자를 포함하는 분말의 제조방법, 그에의해 제조된 분말 및 이를 포함하는 약학적 조성물
KR101128450B1 (ko) 2008-12-11 2012-03-28 (주)바이오제닉스 안정화제로서 β-싸이클로덱스트린 유도체를 포함하는 조성물
JP5841048B2 (ja) 2009-05-14 2016-01-06 エウロメッド・エセ・ア ウイルス性肝炎の治療のための非晶質シリビニン
WO2011044638A1 (en) 2009-10-15 2011-04-21 Howard J. Smith & Associates Pty Ltd Method of treatment of liver disease
CN101810660B (zh) 2009-12-31 2011-06-08 江苏健佳药业有限公司 水溶性水飞蓟素及其制备方法
CN102106819A (zh) 2010-12-29 2011-06-29 中国药科大学 药物-环糊精包合物自微乳组合物的制备方法及应用
US8877259B2 (en) 2012-02-09 2014-11-04 Mary Kay Inc. Cosmetic formulation
CN105816422B (zh) * 2015-01-05 2020-08-14 天士力医药集团股份有限公司 一种水飞蓟宾注射剂及其制备方法
CN108348560A (zh) 2015-03-19 2018-07-31 锡德克斯药物公司 包含水飞蓟素和磺烃基醚环糊精的组合物及其使用方法

Also Published As

Publication number Publication date
ES3029362T3 (en) 2025-06-24
EP3939582C0 (en) 2025-04-30
EP4620534A3 (en) 2025-12-24
JP6971963B2 (ja) 2021-11-24
JP7239640B2 (ja) 2023-03-14
US20230233638A1 (en) 2023-07-27
US11382944B2 (en) 2022-07-12
CA2980170A1 (en) 2016-09-22
EP3270941A4 (en) 2019-05-01
CN108348560A (zh) 2018-07-31
MX384365B (es) 2025-03-14
MX2021008312A (es) 2021-08-05
JP2021143210A (ja) 2021-09-24
WO2016149685A1 (en) 2016-09-22
US20260091073A1 (en) 2026-04-02
EP4620534A2 (en) 2025-09-24
US20180133274A1 (en) 2018-05-17
HK1250016A1 (zh) 2018-11-23
EP3270941B1 (en) 2021-05-26
US20200330539A1 (en) 2020-10-22
US12390506B2 (en) 2025-08-19
EP3939582B1 (en) 2025-04-30
EP3270941A1 (en) 2018-01-24
EP3939582A1 (en) 2022-01-19
JP2018510220A (ja) 2018-04-12
MX2017011966A (es) 2018-06-06
US10702568B2 (en) 2020-07-07

Similar Documents

Publication Publication Date Title
HRP20211303T1 (hr) Pripravci koji sadrže silimarin i sulfoalkil eter ciklodekstrin i postupci korištenja istih
ES2625747T3 (es) Composición para limpieza personal que comprende agentes gelificantes y de formación de espuma para la impregnación de tejido
RU2014152445A (ru) Композиции на основе диклофенака
BR112014031168B1 (pt) Método não terapêutico para a estimulação da biossíntese de hialuronana, composição farmacêutica ou dermatológica, e uso da mesma
JP2013155174A (ja) タンゲレチン及びｅｇｃｇを含有する皮膚外用剤組成物
JP2025087752A (ja) シリバム・マリアナム（Ｓｉｌｙｂｕｍ ｍａｒｉａｎｕｍ）抽出物を老化細胞標的処置剤（ｓｅｎｏｔｈｅｒａｐｅｕｔｉｃ ａｇｅｎｔ）として含む組成物
WO2020263188A1 (en) Triterpenoids that decrease lipid production in sebocytes
CN107616947A (zh) 一种具有头皮护理作用的护发素
JP2018526458A (ja) スキンケア組成物
JP2016074621A (ja) 透明化粧料および該透明化粧料の製造方法
JP6874320B2 (ja) 頭皮用剤
JP2001354579A (ja) 抗炎症化粧料
ES2573478T3 (es) Utilización de composiciones que comprenden por lo menos un lignano y/o neolignano para modular la tasa de testosterona
CN103027875B (zh) 含有乌梅提取物的缓解皮肤刺激用组合物
EP2711050A1 (de) Zusammensetzung sowie kosmetische Zubereitung mit einer derartigen Zusammensetzung
CN109789073B (zh) 用于皮肤保湿或皮肤美白的、含五环三萜咖啡酸酯的组合物
RU2014118775A (ru) Композиции, содержащие экстракты bursera simaruba
WO2016139125A1 (de) Kosmetische mittel mit bio-aktivstoff und einem dipeptid
TW201521737A (zh) 含人參皂苷Ｒh４的皮膚外用組成物
US20170252390A1 (en) Topical skin care formulation
CN106714779A (zh) 用于改善皮肤皱纹的化妆品组合物
JP4027949B2 (ja) 養毛剤
WO2020263190A1 (en) Xanthones that decrease lipid production in sebocytes
JP7481876B2 (ja) コラーゲンに関連した処置のための剤
JP2015020949A (ja) ＰＧＤ２産生抑制剤と５α−リダクターゼ活性阻害剤とを含有する頭髪化粧料及び皮膚化粧料